Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in chronic myeloid leukemia: a single institution study-Reference-Cited by-同舟云学术

Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in chronic myeloid leukemia: a single institution study

Published:2013-03-18 Issue:6 Volume:90 Page:531-532
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Levato Luciano¹,Cantaffa Renato¹,Kropp Maria Grazia¹,Magro Domenico¹,Piro Eugenio¹,Molica Stefano¹

Affiliation:

1. Department Hematology-Oncology; Azienda Ospedaliera Pugliese-Ciaccio; Catanzato; Italy

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12096/fullpdf

Reference11 articles.

1. Characterization of AMN107, a selective inhibitor of native and mutant BCR-ABL;Weisberg;Cancer Cell,2005

2. In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants;O'Hare;Cancer Res,2005

3. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia;Saglio;N Engl J Med,2010

4. Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up;Larson;Leukemia,2012

5. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia;Kantarjian;N Engl J Med,2010

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a 3D Perfused In Vitro System to Assess Proangiogenic Properties of Compounds;Methods and Protocols;2023-12-09

2. Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies;Current Treatment Options in Oncology;2023-12

3. Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL;Advanced Science;2023-07-14

4. Vascular disease during cancer therapy;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023

5. Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders;Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders;2023